bpc 157 nhs | Gastric Pentadecapeptide BPC-157 - LeadWest Medical
Description
They are supplied exclusively for in-vitro and pre-clinical research purposes
Very nervous to get dose #2
Clinical trials confirmed no effect on serum IGF-1, no negative impact on carbohydrate metabolism, and excellent tolerability with safety profile indistinguishable from placebo
Disclaimer: The views and opinions expressed in this blog are solely those of the author, based on clinical experience and research
